Re: Continuation of Consulting Services AgreementOriginal Consulting Services Agreement • November 8th, 2011 • Pharmacyclics Inc • Pharmaceutical preparations
This letter (“Amendment”), when countersigned by you, shall memorialize the terms of your continued consulting arrangement with Pharmacyclics, Inc. (“Pharmacyclics” or the “Company”). As I outlined in my September 22, 2011 email (“September Email”), and as you and Bob Duggan recently discussed, rather than terminate your existing Consulting Services Agreement pursuant to our earlier discussions, we have agreed that you will continue to act as a consultant for the Company. The following sets forth the terms and conditions of your continued provision of consulting services:
